TYRX: Study shows significant decline in cardiac infections with antibacterial envelope
DENVER - TYRX Inc . said its AIGISRx Antibacterial Envelope significantly reduced device infection rates in patients at high risk for device infection who received cardiovascular implantable... Read More
Monday May 13, 2013